Medical News

RSS

Contaminated cocaine may lead to public health epidemic

Doctors warned of a potential public health epidemic in a recent report on patients in Los Angeles and New York who developed serious skin reactions after smoking or snorting cocaine believed to be contaminated with a veterinary medication drug dealers are using to dilute, or "cut," up to 70% of the cocaine in the U.S.

20 Jun 2011

FDA's new strategy calls for coalitions of international regulators, increased data sharing

The U.S. Food and Drug Administration today unveiled a new strategy to meet the challenges posed by rapidly rising imports of FDA-regulated products and a complex global supply chain in a report called the "Pathway to Global Product Safety and Quality."

20 Jun 2011

Small health facilities, solo practices face health IT challenges

As part of the federal government's push to get hospitals and clinics to adopt electronic medical records, it's subsidizing IT training classes across the country. ...

20 Jun 2011

Photocure launches Photodynamic Cosmetic for improving skin appearance

Photocure, the world leader in photodynamic technology today announced the commercial launch of Allumera in the US, the first Photodynamic Cosmetic specifically formulated to improve the overall appearance of skin, reduce outward signs of aging and minimize the appearance of pores with minimal downtime and results that last.

20 Jun 2011

Derma Sciences to raise $29M through private placement

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has entered into definitive agreements with select institutional investors to raise gross proceeds of approximately $29 million.

20 Jun 2011

The complexities of Medicare's doctor pay dynamics

The Medicare physician payment formula is often attacked as a budget gimmick that holds down federal spending on paper, even though everyone knows the cuts it imposes will never come into effect.

20 Jun 2011

Hardin Memorial Hospital selects ProVation Order Sets

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Hardin Memorial Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the organization's electronic order set solution.

20 Jun 2011

New shoulder pad technology allows quicker access to injured players

Riddell today unveiled a new shoulder pad technology that could significantly improve the way in which spine and head injuries can be treated on the football field. The Riddell RipKord is being featured at the National Athletic Trainer's Association (NATA) 62nd Annual Meeting & Clinical Symposia this week in New Orleans.

20 Jun 2011

Medicare, Medicaid increasingly become hot topics in debt-ceiling talks

The future of these entitlement programs will be in play this week as negotiations continue, with both parties beginning to make concessions and hint that a deal could emerge.

20 Jun 2011

NanoViricides plans to lease new cGMP manufacturing and lab space

NanoViricides, Inc. announced today that it will be leasing new space for cGMP production of its nanoviricides drug candidates against various viral diseases.

20 Jun 2011

Genetic Technologies introduces BREVAGen genetic test for assessing non-familial breast cancer risk

Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.

20 Jun 2011

Hospitals hope to make primary care docs salaried employees

In one of the first concrete steps to remake the way medical care is delivered, hospitals are competing to hire primary-care physicians, trying to lure them from their private practices to work as salaried employees alongside specialists (Sun, 6/19).

20 Jun 2011

Supreme Court ruling would affect around 10,000 Reglan-metoclopramide lawsuits

The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No. 09-993, Actavis v Mensing No.08-3850 and Actavis v Demahy No. 09-1501) All three cases involve patients who took metoclopramide, the generic version of the brand-name drug Reglan.

20 Jun 2011

Panacea Global announces name change

Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.

20 Jun 2011

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

Alder Biopharmaceuticals Inc. today announced it will receive a $15 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2b clinical trial in rheumatoid arthritis for ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6).

20 Jun 2011

Neogen announces acquisition of VeroMara

Neogen Corporation announced today that it has acquired the assets of the VeroMara seafood testing laboratory from its parent company, GlycoMar Ltd.

20 Jun 2011

Meditation increases concentration and decreases stress

The nation's current healthcare crisis has added a new dimension to the old saying, "Prevention is the best medicine." With rising co-pays, high deductibles, confusion over coverage, and prescription drug headaches, healthcare consumers recognize that getting sick is more complicated than ever.

20 Jun 2011

Valencell receives $5.5M in Series B venture investment

Valencell, an innovator in mobile health and fitness technology, announced today that it has received $5.5 million in Series B venture investment. The round was led by Best Buy Capital, the investment group of Best Buy Co., Inc., with participation from Series A investors TDF and True Ventures.

20 Jun 2011

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Randox Laboratories, the international clinical diagnostics company, has today launched an automated laboratory assay for Heart-type Fatty Acid Binding Protein (H-FABP), to improve the diagnosis and management of patients with suspected acute coronary syndrome (ACS).

From Randox Laboratories Ltd. 20 Jun 2011

Medidata to acquire Clinical Force

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that it has entered into a definitive agreement to acquire Clinical Force, a pioneer in providing SaaS-based clinical trial management systems (CTMS), for undisclosed proceeds.

20 Jun 2011